COVID-19 among fit patients with CLL treated with venetoclax-based combinations.

Authors :: Fürstenau M
Langerbeins P
De Silva N
Fink AM
Robrecht S
von Tresckow J
Simon F
Hohloch K
Droogendijk J
van der Klift M
van der Spek E
Illmer T
Schöttker B
Fischer K
Wendtner CM
Tausch E
Stilgenbauer S
Niemann CU
Gregor M
Kater AP
Hallek M
Eichhorst B
Source :: Leukemia [Leukemia] 2020 Aug; Vol. 34 (8), pp. 2225-2229. Date of Electronic Publication: 2020 Jun 29.
Publication Year :: 2020

Subjects :: Adenine analogs & derivatives
Aged
Antibodies, Monoclonal, Humanized administration & dosage
Bridged Bicyclo Compounds, Heterocyclic administration & dosage
COVID-19
Coronavirus Infections diagnosis
Coronavirus Infections virology
Female
Follow-Up Studies
Humans
Leukemia, Lymphocytic, Chronic, B-Cell pathology
Leukemia, Lymphocytic, Chronic, B-Cell virology
Male
Middle Aged
Pandemics
Piperidines
Pneumonia, Viral diagnosis
Pneumonia, Viral virology
Prognosis
Pyrazoles administration & dosage
Pyrimidines administration & dosage
Rituximab administration & dosage
SARS-CoV-2
Sulfonamides administration & dosage
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Betacoronavirus isolation & purification
Coronavirus Infections transmission
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Pneumonia, Viral transmission

Full Text Access

Tools